Across TCGA pan-cancer cohorts, PROCR RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated PROCR data layer compared with 4 for mutation status and 5 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PROCR RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PROCR expression acts as an unfavorable survival marker, although some lineages such as MESO and READ show a favorable association.
KIRP, MESO, and READ are the cancer types where PROCR RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.